AVXL — ANAVEX LIFE SCIENCES CORP

Public company

Sign in to save2 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying AVXL?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
75
Institutional Conviction
Strong distribution · 1 buying vs 3 selling last quarter
18
Macro Tailwind
Macro conditions are a headwind for this sector
38
Why? — Evidence & Confidence ▾

Of 4 tracked investors who changed their AVXL position last quarter, 1 bought and 3 sold (25% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).

Supporting evidence
  • +1 tracked investor added or increased positions last quarter (Ken Griffin)
  • +2 tracked investors reported holding AVXL at their latest filing
Contradicting evidence — always shown
  • −3 tracked investors reduced or exited last quarter (1 reduced, 2 sold out)
  • −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.

About ANAVEX LIFE SCIENCES CORP (AVXL)

ANAVEX LIFE SCIENCES CORP (AVXL) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $7M. Across recent filings, tracked investors recorded 7 new positions, 5 increased, 6 reduced, and 6 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in AVXL

50
/100
Mixed Activity
Added / Increased12
Reduced6
Exited6
BearishBullish
Crowded Trade Score™

How many top investors track AVXL

13
/100
Undiscovered
2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded
151015+

AVXL Ownership Composition

How ANAVEX LIFE SCIENCES CORP is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
100% of tracked value
Institutions
2
tracked investors
Total Reported
$1.7M
combined 13F value
Types1
  • Multi-Strategy / Quant100.0%
Multi-Strategy / Quant(2)
100.0%

Tracked investors currently reporting AVXL

2 tracked investors have since exited this position — listed separately below.

  • Ken GriffinSep 30, 2026
    Citadel Advisors
    Shares
    780.5K
    Value
    $1.6M
    % Portfolio
    0.00%
  • Steve CohenSep 30, 2026
    Point72 Asset Management
    Shares
    77.5K
    Value
    $156.6K
    % Portfolio
    0.00%

Previously held AVXL

These investors reported AVXL in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Izzy EnglanderMillennium Management60.5K$156.7KJun 30, 2026
Paul Tudor JonesTudor Investment Corp20.4K$52.8KJun 30, 2026

Recent activity

Frequently asked questions

How many institutional investors hold AVXL?
2 tracked institutional investors disclosed a position in AVXL (ANAVEX LIFE SCIENCES CORP) in their most recent 13F filing.
Who is the largest institutional holder of AVXL?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in AVXL, valued at $7M.
Did institutional ownership of AVXL increase or decrease?
Across recent 13F filings, tracked investors recorded 7 new positions, 5 increased, 6 reduced, and 6 fully exited AVXL.
Where does this AVXL ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
AVXL (ANAVEX LIFE SCIENCES CORP) — Institutional Holders & — InvestorLens